Version history

{
  "kind": "infographic",
  "prompt": "Drug-Specific Mechanisms: Challenging the Final Common Pathway figure 4",
  "provider": "other",
  "raw_fields": {
    "papers": [
      {
        "n": null,
        "doi": "10.1016/j.addicn.2025.100230",
        "value": "85%",
        "method": "various",
        "metric": "alcohol pharmacological action",
        "cite_key": "Tyler2025",
        "n_analyzed": null,
        "text_access": "fulltext",
        "n_definition": "animals or subjects",
        "scope_region": "CNS",
        "study_system": "rats",
        "taxonomic_level": "molecular target",
        "scope_population": "ethanol-exposed",
        "value_source_sentence": "For Pavlovian drug discrimination (Experiment 1) and alcohol metabolism (Experiment 2), rats were fed daily to maintain 85 % of free-feeding weight.",
        "experimental_conditions": "TMT exposure produced a leftward shift in the alcohol dose-response curve, indicating increased inte"
      },
      {
        "n": 2,
        "doi": "10.1016/j.alcohol.2009.09.027",
        "value": "30%",
        "method": "various",
        "metric": "alcohol pharmacological action",
        "cite_key": "Bell2009",
        "n_analyzed": 2,
        "text_access": "abstract_only",
        "n_definition": "animals or subjects",
        "scope_region": "CNS",
        "study_system": "rats",
        "taxonomic_level": "molecular target",
        "scope_population": "ethanol-exposed",
        "value_source_sentence": "Adult male HAD-2 rats were given access to ethanol (15 and 30%, with ad libitum access to water and food) 22 h/day for 12 weeks, beginning at 60 days of age, after which cytisine (0.0, 0.5, and 1.5 mg/kg) was tested for 3 consecutive days.",
        "experimental_conditions": "These findings provide further evidence that activity at the nAChR influences ethanol intake and is "
      },
      {
        "n": 157,
        "doi": "10.1176/appi.ajp.20250115",
        "value": "7.2%",
        "method": "various",
        "metric": "alcohol pharmacological action",
        "cite_key": "Metrik2026",
        "n_analyzed": 157,
        "text_access": "abstract_only",
        "n_definition": "animals or subjects",
        "scope_region": "CNS",
        "study_system": "rats",
        "taxonomic_level": "molecular target",
        "scope_population": "ethanol-exposed",
        "value_source_sentence": "The aim of this double-blind crossover randomized clinical trial was to examine dose-dependent acute effects of delta-9-tetrahydrocannabinol (THC) on alcohol craving and consumption.<h4>Methods</h4>Across three experimental days, 157 participants reporting heavy alcohol use and cannabis use two or more times weekly were randomized to smoke cannabis cigarettes containing 7.2% THC, 3.1% THC, or 0.03% THC (placebo), followed by exposures to neutral and personalized alcohol cues and an alcohol choice task for alcohol self-administration.",
        "experimental_conditions": "<h4>Objective</h4>Cannabis use is strongly linked with heavy drinking and worse alcohol treatment ou"
      },
      {
        "n": 56,
        "doi": "10.1038/s43856-025-01369-6",
        "value": null,
        "method": "various",
        "metric": "alcohol pharmacological action",
        "cite_key": "Farahbakhsh2026",
        "n_analyzed": 56,
        "text_access": "abstract_only",
        "n_definition": "animals or subjects",
        "scope_region": "CNS",
        "study_system": "mice",
        "taxonomic_level": "molecular target",
        "scope_population": "ethanol-exposed",
        "value_source_sentence": "After acquiring operant responding for ethanol, each subject underwent four treatment block conditions: nalmefene (0.1 mg/kg i.p.), naltrexone (1.0 mg/kg i.p.), the selective kappa opioid receptor agonist U50,488 (1.0 mg/kg i.p.) and placebo (saline 10 ml/kg i.p.).",
        "experimental_conditions": "A predictive model based on circulating biogenic amines allows for high accuracy classification of n"
      },
      {
        "n": null,
        "doi": "10.1002/npr2.70033",
        "value": "81.5%",
        "method": "various",
        "metric": "alcohol pharmacological action",
        "cite_key": "Masataka2025",
        "n_analyzed": null,
        "text_access": "abstract_only",
        "n_definition": "animals or subjects",
        "scope_region": "CNS",
        "study_system": "human",
        "taxonomic_level": "molecular target",
        "scope_population": "ethanol-exposed",
        "value_source_sentence": "A Sankey diagram visualized substance use progression, and odds ratios were calculated to assess the likelihood of using other substances following cannabis use.<h4>Results</h4>Of all respondents, 81.5% were male, with the largest age group being 20-24.",
        "experimental_conditions": "Odds for subsequent use of alcohol, tobacco, methamphetamine, and other illicit drugs after cannabis"
      }
    ],
    "comparison_id": "fig_sec5_alcohol_multitarget",
    "comparison_type": "pharmacological_comparison",
    "homogeneity_check": {
      "caveats": [
        "Different molecular targets assessed with different methodologies",
        "Dose-response relationships differ across targets",
        "Acute vs chronic effects are often conflated in comparisons"
      ],
      "comparable": true,
      "n_definition": "varies by study",
      "scope_region": "multiple brain regions",
      "taxonomic_level": "molecular target",
      "scope_population": "ethanol-exposed preparations"
    },
    "suggested_plot_type": "radar_or_summary"
  },
  "section_id": "section_05_evidence",
  "source_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewAddiction/blob/43d33061a22aa4fed3f7dc71fabbfa48ab1d6f48/evidence/section_05_evidence.json",
  "target_ref": "wiki_page:computationalreviewaddiction-05",
  "review_repo": "ComputationalReviewAddiction",
  "section_ref": "wiki_page:computationalreviewaddiction-05",
  "source_path": "evidence/section_05_evidence.json",
  "source_refs": [
    "paper:paper-05847d71e023",
    "paper:paper-3ef37a571281",
    "paper:paper-a272f5ab95ab",
    "paper:paper-b1dfab2ca902",
    "paper:paper-cd366a80e3ce"
  ],
  "section_title": "Drug-Specific Mechanisms: Challenging the Final Common Pathway",
  "source_policy": {
    "mode": "public_source_pointer_with_short_context",
    "notes": [
      "Local review repositories are read-only inputs.",
      "SciDEX stores paper metadata, structured evidence, file pointers, and short citation contexts; it does not copy full review prose."
    ],
    "source_commit_sha": "43d33061a22aa4fed3f7dc71fabbfa48ab1d6f48",
    "source_repository_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewAddiction"
  },
  "generation_status": "complete",
  "review_bundle_ref": "analysis_bundle:ab-d95cfb705572",
  "origin_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewAddiction/blob/43d33061a22aa4fed3f7dc71fabbfa48ab1d6f48/evidence/section_05_evidence.json",
  "commit_sha": "43d33061a22aa4fed3f7dc71fabbfa48ab1d6f48",
  "created_by": "persona-jerome-lecoq-gbo-neuroscience",
  "repository_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewAddiction"
}